ANDA 40457, held by Impax Labs Inc. Pyridostigmine Bromide.
As of Nov 16, 2026, ANDA 40457 (Pyridostigmine Bromide), held by Impax Labs Inc, was first approved by FDA on Dec 26, 2002, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 26, 2002 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Pyridostigmine Bromide60MG ยท tablet;oral | Pyridostigmine Bromide | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters